Takeda Pharmaceutical Company Limited
Anti-CD38 antibodies
Last updated:
Abstract:
Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.
Status:
Grant
Type:
Utility
Filling date:
17 Oct 2019
Issue date:
6 Sep 2022